title: Reply to 'Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''.
authors.affiliation: Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.|Department of Biostatistics, The University of Texas Health Science Center at Houston School of Public Health, 1200 Pressler Street, Houston, TX 77030, USA.
authors.forename: Takeo
authors.initials: T
authors.lastname: Fujii
authors.affiliation: Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
authors.forename: Naoto T
authors.initials: NT
authors.lastname: Ueno
mesh_terms: D001943:Breast Neoplasms; D006801:Humans; D020360:Neoadjuvant Therapy; D049451:Nomograms; D018719:Erb-b2 Receptor Tyrosine Kinases
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases